Find CKD-516 free base manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

0

USDMF

0

CEP/COS

0

JDMF

0

EU WC

0

KDMF

0

NDC API

0

VMF

0

Listed Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

0

FDA Orange Book

0

Europe

0

Canada

0

Australia

0

South Africa

0

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API/FDF Prices: Book a Demo

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Valecobulin, 1188371-47-2, Ckd-516, P48p97v001, (2s)-2-amino-3-methyl-n-[4-[3-(1,2,4-triazol-1-yl)-4-(3,4,5-trimethoxybenzoyl)phenyl]-1,3-thiazol-2-yl]butanamide, Unii-p48p97v001
Molecular Formula
C26H28N6O5S
Molecular Weight
536.6  g/mol
InChI Key
UKKRUIXIDCWALA-QFIPXVFZSA-N
FDA UNII
P48P97V001

CKD-516 free base
Valecobulin is a benzophenone derivative and water soluble valine prodrug of the tubulin binding agent S516, with potential tubulin-inhibiting, vascular-disrupting and antineoplastic activity. Upon administration, valecobulin is converted into its active metabolite S-516 that binds to tubulin and prevents its polymerization in tumor blood vessel endothelial cells and tumor cells. This blocks the formation of the mitotic spindle and leads to cell cycle arrest at the G2/M phase. As a result, this agent disrupts the tumor vasculature and tumor blood flow, deprives tumor cells of nutrients and induces tumor cell apoptosis. In addition, this agent has a direct cytotoxic effect on tumor cells by inhibiting tubulin polymerization.
1 2D Structure

CKD-516 free base

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-2-amino-3-methyl-N-[4-[3-(1,2,4-triazol-1-yl)-4-(3,4,5-trimethoxybenzoyl)phenyl]-1,3-thiazol-2-yl]butanamide
2.1.2 InChI
InChI=1S/C26H28N6O5S/c1-14(2)22(27)25(34)31-26-30-18(11-38-26)15-6-7-17(19(8-15)32-13-28-12-29-32)23(33)16-9-20(35-3)24(37-5)21(10-16)36-4/h6-14,22H,27H2,1-5H3,(H,30,31,34)/t22-/m0/s1
2.1.3 InChI Key
UKKRUIXIDCWALA-QFIPXVFZSA-N
2.1.4 Canonical SMILES
CC(C)C(C(=O)NC1=NC(=CS1)C2=CC(=C(C=C2)C(=O)C3=CC(=C(C(=C3)OC)OC)OC)N4C=NC=N4)N
2.1.5 Isomeric SMILES
CC(C)[C@@H](C(=O)NC1=NC(=CS1)C2=CC(=C(C=C2)C(=O)C3=CC(=C(C(=C3)OC)OC)OC)N4C=NC=N4)N
2.2 Other Identifiers
2.2.1 UNII
P48P97V001
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Ckd 516

2. Ckd-516

3. Ckd516

4. N-(4-(3-(1h-1,2,4-triazol-1-yl)-4-(3,4,5-trimethoxybenzoyl)phenyl)thiazol-2-yl)-2-amino-3-methylbutanamide

2.3.2 Depositor-Supplied Synonyms

1. Valecobulin

2. 1188371-47-2

3. Ckd-516

4. P48p97v001

5. (2s)-2-amino-3-methyl-n-[4-[3-(1,2,4-triazol-1-yl)-4-(3,4,5-trimethoxybenzoyl)phenyl]-1,3-thiazol-2-yl]butanamide

6. Unii-p48p97v001

7. Valecobulin [inn]

8. Schembl1044849

9. Chembl1270189

10. Dtxsid20152252

11. Ac-35663

12. Hy-13598

13. Cs-0007394

14. Q27286132

15. Butanamide, 2-amino-3-methyl-n-(4-(3-(1h-1,2,4-triazol-1-yl)-4-(3,4,5-trimethoxybenzoyl)phenyl)-2-thiazolyl)-, (2s)-

2.4 Create Date
2009-11-02
3 Chemical and Physical Properties
Molecular Weight 536.6 g/mol
Molecular Formula C26H28N6O5S
XLogP33.6
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count10
Rotatable Bond Count10
Exact Mass536.18418919 g/mol
Monoisotopic Mass536.18418919 g/mol
Topological Polar Surface Area172 Ų
Heavy Atom Count38
Formal Charge0
Complexity794
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

ABOUT THIS PAGE

Looking for 1188371-47-2 / CKD-516 free base API manufacturers, exporters & distributors?

CKD-516 free base manufacturers, exporters & distributors 1

12

PharmaCompass offers a list of CKD-516 free base API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right CKD-516 free base manufacturer or CKD-516 free base supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred CKD-516 free base manufacturer or CKD-516 free base supplier.

PharmaCompass also assists you with knowing the CKD-516 free base API Price utilized in the formulation of products. CKD-516 free base API Price is not always fixed or binding as the CKD-516 free base Price is obtained through a variety of data sources. The CKD-516 free base Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

CKD-516 free base

Synonyms

Valecobulin, 1188371-47-2, Ckd-516, P48p97v001, (2s)-2-amino-3-methyl-n-[4-[3-(1,2,4-triazol-1-yl)-4-(3,4,5-trimethoxybenzoyl)phenyl]-1,3-thiazol-2-yl]butanamide, Unii-p48p97v001

Cas Number

1188371-47-2

Unique Ingredient Identifier (UNII)

P48P97V001

About CKD-516 free base

Valecobulin is a benzophenone derivative and water soluble valine prodrug of the tubulin binding agent S516, with potential tubulin-inhibiting, vascular-disrupting and antineoplastic activity. Upon administration, valecobulin is converted into its active metabolite S-516 that binds to tubulin and prevents its polymerization in tumor blood vessel endothelial cells and tumor cells. This blocks the formation of the mitotic spindle and leads to cell cycle arrest at the G2/M phase. As a result, this agent disrupts the tumor vasculature and tumor blood flow, deprives tumor cells of nutrients and induces tumor cell apoptosis. In addition, this agent has a direct cytotoxic effect on tumor cells by inhibiting tubulin polymerization.

CKD-516 free base Manufacturers

A CKD-516 free base manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CKD-516 free base, including repackagers and relabelers. The FDA regulates CKD-516 free base manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CKD-516 free base API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

CKD-516 free base Suppliers

A CKD-516 free base supplier is an individual or a company that provides CKD-516 free base active pharmaceutical ingredient (API) or CKD-516 free base finished formulations upon request. The CKD-516 free base suppliers may include CKD-516 free base API manufacturers, exporters, distributors and traders.

CKD-516 free base GMP

CKD-516 free base Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of CKD-516 free base GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CKD-516 free base GMP manufacturer or CKD-516 free base GMP API supplier for your needs.

CKD-516 free base CoA

A CKD-516 free base CoA (Certificate of Analysis) is a formal document that attests to CKD-516 free base's compliance with CKD-516 free base specifications and serves as a tool for batch-level quality control.

CKD-516 free base CoA mostly includes findings from lab analyses of a specific batch. For each CKD-516 free base CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

CKD-516 free base may be tested according to a variety of international standards, such as European Pharmacopoeia (CKD-516 free base EP), CKD-516 free base JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CKD-516 free base USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty